Matches in Wikidata for { <http://www.wikidata.org/entity/Q80029235> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q80029235 description "artículu científicu espublizáu n'abril de 2007" @default.
- Q80029235 description "im April 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80029235 description "scientific article published on 01 April 2007" @default.
- Q80029235 description "wetenschappelijk artikel" @default.
- Q80029235 description "наукова стаття, опублікована у квітні 2007" @default.
- Q80029235 name "Re: Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer: C. W. Ryan, D. Huo, L. M. Demers, T. M. Beer and L. V. Lacerna. J Urol 2006; 176: 972-978" @default.
- Q80029235 name "Re: Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer: C. W. Ryan, D. Huo, L. M. Demers, T. M. Beer and L. V. Lacerna. J Urol 2006; 176: 972-978" @default.
- Q80029235 type Item @default.
- Q80029235 label "Re: Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer: C. W. Ryan, D. Huo, L. M. Demers, T. M. Beer and L. V. Lacerna. J Urol 2006; 176: 972-978" @default.
- Q80029235 label "Re: Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer: C. W. Ryan, D. Huo, L. M. Demers, T. M. Beer and L. V. Lacerna. J Urol 2006; 176: 972-978" @default.
- Q80029235 prefLabel "Re: Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer: C. W. Ryan, D. Huo, L. M. Demers, T. M. Beer and L. V. Lacerna. J Urol 2006; 176: 972-978" @default.
- Q80029235 prefLabel "Re: Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer: C. W. Ryan, D. Huo, L. M. Demers, T. M. Beer and L. V. Lacerna. J Urol 2006; 176: 972-978" @default.
- Q80029235 P1433 Q80029235-32EDB642-C218-424A-9803-C0DC8BD9B590 @default.
- Q80029235 P1476 Q80029235-6E5B644F-9BDF-4314-9641-08845103ECF1 @default.
- Q80029235 P2093 Q80029235-227EE4D2-2C5C-4C1A-A7C9-BF5BF2CED22A @default.
- Q80029235 P2093 Q80029235-7049ADC0-3A59-481F-89FB-162FEB396F2C @default.
- Q80029235 P2093 Q80029235-87F789EE-A339-4A46-B952-8B3BCFD6CF70 @default.
- Q80029235 P304 Q80029235-E4B9F3B5-1DF2-483E-8CA1-38779BE6031F @default.
- Q80029235 P31 Q80029235-3179F339-3462-4999-8AD3-4F433463B76F @default.
- Q80029235 P356 Q80029235-B46877F1-B974-4D26-BAAE-A66D2E0EF030 @default.
- Q80029235 P433 Q80029235-4FABD718-3396-4C71-B737-5460C1BC3567 @default.
- Q80029235 P478 Q80029235-B47CBA20-6E2C-4E79-9D7D-79E5B5652D91 @default.
- Q80029235 P577 Q80029235-00FAB612-1BF6-4C52-B418-31FD93928274 @default.
- Q80029235 P698 Q80029235-3E9362F5-3906-4B53-B312-9EC7D2BC3F98 @default.
- Q80029235 P921 Q80029235-83713D6E-3843-4E7D-8286-EBB49FF91E48 @default.
- Q80029235 P356 J.JURO.2006.11.053 @default.
- Q80029235 P698 17382782 @default.
- Q80029235 P1433 Q15709979 @default.
- Q80029235 P1476 "Re: Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer: C. W. Ryan, D. Huo, L. M. Demers, T. M. Beer and L. V. Lacerna. J Urol 2006; 176: 972-978" @default.
- Q80029235 P2093 "John T Wei" @default.
- Q80029235 P2093 "Rodney L Dunn" @default.
- Q80029235 P2093 "Scott M Gilbert" @default.
- Q80029235 P304 "1584-5; author reply 1585" @default.
- Q80029235 P31 Q13442814 @default.
- Q80029235 P356 "10.1016/J.JURO.2006.11.053" @default.
- Q80029235 P433 "4" @default.
- Q80029235 P478 "177" @default.
- Q80029235 P577 "2007-04-01T00:00:00Z" @default.
- Q80029235 P698 "17382782" @default.
- Q80029235 P921 Q218507 @default.